Type to search

Somalogic Acquires DNA Nanotechnology Leader Palamedrix to Develop the Next-generation SomaScan® Assay | Pharmtech Focus
format_quote SomaLogic Announces License Agreement with OncoHost for the Development of Precision Cancer Diagnostics | Pharmtech Focus
Major Journal Publishes Landmark Proteomics Study Demonstrating Development of an Unprecedented New Clinical Cardiovascular Risk Test | Pharmtech Focus